In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017

Eravacycline is a novel, fully synthetic fluorocycline antibiotic developed for the treatment of serious infections, including those caused by multidrug-resistant (MDR) pathogens. Here, we evaluated the in vitro activities of eravacycline and comparator antimicrobial agents against a global collecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Morrissey, Ian, Olesky, Melanie, Hawser, Stephen, Lob, Sibylle H., Karlowsky, James A., Corey, G. Ralph, Bassetti, Matteo, Fyfe, Corey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Epidemiology and Surveillance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038303/
https://www.ncbi.nlm.nih.gov/pubmed/31843999
http://dx.doi.org/10.1128/AAC.01699-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038303/
https://www.ncbi.nlm.nih.gov/pubmed/31843999
http://dx.doi.org/10.1128/AAC.01699-19

Ejemplares similares